FindTrial
Sign In

Technetium Tc-99m Albumin Aggregated

RADIATION3 trials

Sponsors

University of Washington, M.D. Anderson Cancer Center

Conditions

Lung CarcinomaMalignant NeoplasmMetastatic Liver CarcinomaStage IIB Lung Non-Small Cell Carcinoma AJCC v7Stage IIIA Lung Non-Small Cell Cancer AJCC v7Stage IIIB Lung Non-Small Cell Cancer AJCC v7Stage IV Liver CancerStage IVA Liver Cancer

Phase 1

Yttrium Y-90 Radioembolization in Treating Patients With Metastatic Liver Cancer
Active, not recruitingNCT03028311
M.D. Anderson Cancer CenterMetastatic Liver Carcinoma, Stage IVA Liver Cancer, Stage IVB Liver Cancer +1
Start: 2017-01-09End: 2027-01-31Target: 12Updated: 2026-03-10

Phase 2

FLARE RT for Patients With Stage IIB-IIIB Non-small Cell Lung Cancer: Personalizing Radiation Therapy Using PET/CT and SPECT/CT Imaging
CompletedNCT02773238
University of WashingtonStage IIB Lung Non-Small Cell Carcinoma AJCC v7, Stage IIIA Lung Non-Small Cell Cancer AJCC v7, Stage IIIB Lung Non-Small Cell Cancer AJCC v7
Start: 2016-05-20End: 2023-12-01Updated: 2024-08-14

Unknown Phase

SPECT/CT in Measuring Lung Function in Patients With Cancer Undergoing Radiation Therapy
CompletedNCT01982123
University of WashingtonLung Carcinoma, Malignant Neoplasm
Start: 2014-01-17End: 2017-09-13Updated: 2018-12-13

Related Papers

GWO+RuleFit: rule-based explainable machine-learning combined with heuristics to predict mid-treatment FDG PET response to chemoradiation for locally advanced non-small cell lung cancer
Physics in Medicine and Biology2024-07-092 citations
Independent association of metabolic tumor response on FDG-PET with pulmonary toxicity following risk-adaptive chemoradiation for unresectable non-small cell lung cancer: Inherent radiosensitivity or immune response?
2023-05-25
Radiation and immune checkpoint inhibitor-mediated pneumonitis risk stratification in patients with locally advanced non-small cell lung cancer: role of functional lung radiomics?
2022-09-0116 citations
Multitask Learning Radiomics on Longitudinal Imaging to Predict Survival Outcomes following Risk-Adaptive Chemoradiation for Non-Small Cell Lung Cancer
Cancers2022-02-2635 citations
Prognostic Value of Early Fluorodeoxyglucose-Positron Emission Tomography Response Imaging and Peripheral Immunologic Biomarkers: Substudy of a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable Non-Small Cell Lung Cancer.
2021-11-213 citations
Prognostic Value and Peripheral Immunologic Correlates of Early FDG PET Response Imaging in a Phase II Trial of Risk-Adaptive Chemoradiation for Unresectable NSCLC.
2021-11-01
Reliability of Quantitative 18F-FDG PET/CT Imaging Biomarkers for Classifying Early Response to Chemoradiotherapy in Patients With Locally Advanced Non–Small Cell Lung Cancer
Clinical Nuclear Medicine2021-06-2517 citations
Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer
Physics in Medicine and Biology2020-08-1913 citations
Abstract 6497: Early assessment of liquid biomarkers to predict pneumonitis after chemoradiation in patients with locally advanced non-small cell lung cancer (LA-NSCLC)
Cancer Research2020-08-153 citations
Prognostic role of mid-treatment PET/CT and plasma cytokines in patients undergoing chemoradiation for locally advanced non-small cell lung cancer (LA-NSCLC).
Journal of Clinical Oncology2020-05-20
Comparison of regional lung perfusion response on longitudinal MAA SPECT/CT in lung cancer patients treated with and without functional tissue-avoidance radiation therapy
British Journal of Radiology2019-07-3118 citations
Voxel Forecast for Precision Oncology: Predicting Spatially Variant and Multiscale Cancer Therapy Response on Longitudinal Quantitative Molecular Imaging
Clinical Cancer Research2019-05-2914 citations